Explore more publications!
The Africa Gazette
Got News to Share?

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 1, 2025

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
October 1, 2025

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

Indeterminate GlobeNewswire
ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
October 1, 2025

ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors

Indeterminate GlobeNewswire
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
October 1, 2025

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

Indeterminate GlobeNewswire
Pasinex Provides Corporate Update: Completion of Sarıkaya Acquisition, AGM, New Board Member and Financing
October 1, 2025

Pasinex Provides Corporate Update: Completion of Sarıkaya Acquisition, AGM, New Board Member and Financing

Indeterminate GlobeNewswire
Guanajuato Silver Announces $30 Million Bought Deal Public Offering
October 1, 2025

Guanajuato Silver Announces $30 Million Bought Deal Public Offering

Indeterminate GlobeNewswire
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
October 1, 2025

Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®

Indeterminate GlobeNewswire
BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business
October 1, 2025

BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business

Indeterminate GlobeNewswire
Neumora Therapeutics to Host Virtual R&D Day on October 27
October 1, 2025

Neumora Therapeutics to Host Virtual R&D Day on October 27

Indeterminate GlobeNewswire
Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer
October 1, 2025

Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer

Indeterminate GlobeNewswire
アキュミュラスシナジー (Accumulus Synergy)、クシュブ・シャルマ (Khushboo Sharma) を最高経営責任者に任命
October 1, 2025

アキュミュラスシナジー (Accumulus Synergy)、クシュブ・シャルマ (Khushboo Sharma) を最高経営責任者に任命

Indeterminate GlobeNewswire
Accumulus Synergy nomme Khushboo Sharma au poste de Chief Executive Officer
October 1, 2025

Accumulus Synergy nomme Khushboo Sharma au poste de Chief Executive Officer

Indeterminate GlobeNewswire
Accumulus Synergy ernennt Khushboo Sharma zur Chief Executive Officer
October 1, 2025

Accumulus Synergy ernennt Khushboo Sharma zur Chief Executive Officer

Indeterminate GlobeNewswire
Verano Secures US $75,000,000 Revolving Credit Facility
October 1, 2025

Verano Secures US $75,000,000 Revolving Credit Facility

Indeterminate GlobeNewswire
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
October 1, 2025

Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Indeterminate GlobeNewswire
Apollo Silver Announces $20.88 Million Private Placement Offering
October 1, 2025

Apollo Silver Announces $20.88 Million Private Placement Offering

Indeterminate GlobeNewswire
Afterprime Launches the Industry’s First Broker That Pays Traders Instead of Charging Them
October 1, 2025

Afterprime Launches the Industry’s First Broker That Pays Traders Instead of Charging Them

Indeterminate GlobeNewswire
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
October 1, 2025

RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

Indeterminate GlobeNewswire
PU Prime Launches Halloween Giveaway: iPhones, Watches & Cash Await
October 1, 2025

PU Prime Launches Halloween Giveaway: iPhones, Watches & Cash Await

Indeterminate GlobeNewswire
Trident Resources Initiates Exploration Program at Greywacke and Hailstone Properties in Saskatchewan
October 1, 2025

Trident Resources Initiates Exploration Program at Greywacke and Hailstone Properties in Saskatchewan

Indeterminate GlobeNewswire
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
October 1, 2025

Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions